Table 1

Clinical details of the 17 patients with idiopathic Parkinson’s disease studied

Patient NoAge (y)Duration (y)Hoehn and Yahr stage (1–5)Motor UPDRS (0–56)Drugs
16962.015Levodopa, amantadine
27432.519Levodopa
36132.019Levodopa
466154.031Levodopa, pergolide, selegiline
55084.030Levodopa, apomorphine,
66421.515Levodopa, pergolide
76142.014Levodopa
86653.025Levodopa
95754.033Levodopa, apomorphine
1076164.040Levodopa, apomorphine, pergolide
115752.517Levodopa
1266162.519Levodopa, benzhexol
135351.012Levodopa
146282.516Levodopa, cabergoline, benzhexol
155551.010Levodopa, entacapone
164741.09Levodopa, entacapone
175922.014Levodopa
  • Duration=Symptom duration in year; motor UPDRS=total motor score of the UPDRS scale for worst clinically affected limbs.